Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sage Therapeutics, Inc. | 0 | reported | 31 Jul 2025 | tx 23+234,967−126,078 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 28,053 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 36,375 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 40,000 | — | deriv |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 12,500 | — | deriv |
| 10 Apr 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 793 | 6.91 USD | |
| 10 Apr 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 661 | 6.91 USD | |
| 10 Apr 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 2,712 | 0.00 USD | |
| 10 Apr 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 3,255 | 0.00 USD | |
| 13 Feb 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 822 | 7.18 USD | |
| 16 Jan 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 16 Jan 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 01 Nov 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 6,250 | 0.00 USD | |
| 01 Nov 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 05 Aug 2024 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 4,755 | 8.96 USD | |
| 05 Aug 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 16,200 | 0.00 USD | |
| 13 Feb 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 13,500 | 0.00 USD | |
| 13 Feb 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 20,900 | 0.00 USD | deriv |
| 03 Feb 2023 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 2,119 | 44.16 USD | |
| 03 Feb 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 6,750 | 0.00 USD | |
| 16 Jun 2022 | GRANT_AWARD | Sage Therapeutics, Inc. | 9,500 | 0.00 USD | deriv |
| 11 Feb 2022 | GRANT_AWARD | Sage Therapeutics, Inc. | 11,400 | 0.00 USD | deriv |
| 01 Oct 2021 | GRANT_AWARD | Sage Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |